Concepedia
Statistics
Publications
26
Citations
970
H-Index
19
Active since
2001
Affiliations
Pfizer (United States)(Current)
Johnson & Johnson (United States)
Janssen (United States)
Chongqing Medical University
The Affiliated Yongchuan Hospital of Chongqing Medical University
Qinying Zhao is an author at Pfizer (United States) specializing in pharmacology, clinical pharmacology, and pharmacokinetics.
Publications per year
2001–2023
Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database
Kaori Ito, Brian Corrigan, Qinying Zhao et al. · Alzheimer s & Dementia · 2010 · 140 citations
Medicine, Biostatistics, Neurology +17
U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors
Kyriakos P. Papadopoulos, Erkut Borazanci, Alice T. Shaw et al. · Clinical Cancer Research · 2020 · 108 citations · Full text
Medicine, Oncology, Pharmacology +15
Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease
Jaren W. Landen, Qinying Zhao, Sharon Cohen et al. · Clinical Neuropharmacology · 2013 · 86 citations
Medicine, Neurology, Pharmacology +17
Perirenal Fat Thickness Is Significantly Associated With the Risk for Development of Chronic Kidney Disease in Patients With Diabetes
Xiangjun Chen, Yun Mao, Jinbo Hu et al. · Diabetes · 2021 · 85 citations · Full text
Medicine, Endocrinology, Nephrology +17
Multiple‐dose ponezumab for mild‐to‐moderate Alzheimer's disease: Safety and efficacy
Jaren W. Landen, Sharon Cohen, Clare B. Billing et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2017 · 62 citations · Full text
Medicine, Neurology, Pharmacotherapy +17
1–5 of 26